Management of acute heart failure
The management of acute heart failure has not evolved for several decades, but has been standardized by recent recommendations that emphasize the need for rapid diagnosis and treatment. Medical treatment is based on diuretics and on vasodilators or inotropes depending on the blood pressure level and the existence of cardiogenic shock signs. Despite serelaxin has not confirmed its efficacy on morbi-mortality in the RELAX-HF2 study, the therapeutic approach of acute heart failure patients could evolve towards two stages. First, an improvement in short-term survival and symptoms, based on decongestant therapy associated with respiratory and/or circulatory support in case of cardio-respiratory distress. Second, a halt of the heart failure vicious circle to reduce the risk of death or re-admission, based on techniques to protect target organs such as the heart, kidneys and the liver.